ATS Medical Announces New Destination Website for People Needing Mechanical Heart Valve Replacement
28 Abril 2010 - 3:50PM
Marketwired
ATS Medical, Inc. (NASDAQ: ATSI), manufacturer and marketer of
state-of-the-art cardiac surgery products and services today
announced the launch of a new website, www.MyHeartValveChoice.com,
that is designed to be a credible key destination for visitors
making mechanical heart valve replacement decisions. Not all
mechanical heart valves are alike. Knowledge of the differences is
important for people looking to gain further understanding about
mechanical (artificial) heart valves in replacement heart valve
surgery. That is what ATS Medical provides for patients,
caregivers, cardiologists and cardiac surgeons when they visit this
new site.
The domain name, MyHeartValveChoice.com, reflects the fact that
patients and caregivers are critical participants in the process of
choosing the mechanical heart valve to be used. With the increasing
reliance on the Internet for information, patients overall have
become better informed in their choices and more than ever are
prepared to ask the right questions affecting decisions that impact
their lives. Greater numbers of Internet users are searching for
medical information about specific issues. According to "The Social
Life of Health Information" report from the Pew Internet &
American Life Project, 61% of U.S. adults go online for health
information. Nearly half search for background on a specific
disease or problem, 41% need to know about a medical procedure and
35% are looking for a doctor.
"We think that the MyHeartValveChoice.com website will afford
patients, caregivers, cardiologists and cardiac surgeons much more
confidence and comfort in their decisions about mechanical heart
valve replacement," said Michael D. Dale, ATS Medical President and
CEO. "We hope it will become an online destination for choosing the
right mechanical heart valve and especially the ATS Open Pivot
Mechanical Heart Valve."
Categorical differences in mechanical heart valve design can
affect valve performance and quality of life. Patients and cardiac
surgeons may not be aware of these. The MyHeartValveChoice.com
website gives patients, caregivers, cardiologists and cardiac
surgeons key information about choosing the right mechanical heart
valve. Included are personal experiences of having a mechanical
valve, clinical information and studies and the advantages of the
ATS Open Pivot® Mechanical Heart Valve. Unlike other websites on
heart valve disease and heart valve replacement, the site provides
in-depth clinical information and specifically clinical experience
with the ATS Open Pivot Mechanical Heart Valve.
The ATS Open Pivot Mechanical Heart Valve has been implanted in
more than 200,000 patients worldwide and is a fundamentally
different design from others. The valve has no cavities where blood
can collect. Instead, leaflets pivot on smooth spherical
projections (open pivots) that are not required to forcefully wash
the pivot area. The result is a valve that reduces the likelihood
of thrombus formation (blood clots), is gentler on the blood
(reduces shear stress), and achieves quieter operation.
The website also provides patients with helpful information for
exploring such topics as how the heart works, complete with
illustrations and a glossary of terms, as well as what to ask the
doctor. Cardiac surgeons become leading resources via the Surgeon
Locator, making it easier for patients to find cardiac surgeons in
their area.
For more than 30 years, mechanical heart valves have
successfully provided patients with the ability to lead healthy,
active, productive lives. Today, 20 to 30% of all patients
diagnosed with heart valve disease receive a mechanical valve.
Surgeons regularly select mechanical valves for their performance
characteristics -- valve durability, thromboresistance (resistance
to forming blood clots), hemodynamic performance (the measure of
blood flowing through the heart valve), implantability (ease of
implant) and patient quality of life.
Mechanical heart valve use is growing globally and ATS Medical
continues to gain market share worldwide. The market for the ATS
Open Pivot Mechanical Heart Valve has increased exponentially in
many parts of the developing world. In China, for example, where
eight out of ten patients receive a mechanical valve, the vast
majority of medical centers now use the ATS Open Pivot valve in
valve replacement surgery.
About ATS Medical
ATS Medical, Inc. is dedicated to 'Advancing The Standards' of
cardiac surgery through the development, manufacturing and
marketing of innovative products and services for the treatment of
structural heart disease. ATS Medical serves the cardiac surgery
community by focusing on two distinct but operationally synergistic
market segments: heart valve disease therapy and surgical ablation
of cardiac arrhythmias.
ATS was originally founded to develop the ATS Open Pivot® Heart
Valve as a new mechanical heart valve standard of care. Today the
ATS Open Pivot Heart Valve is the preferred mechanical heart valve
in many markets around the world and the fastest growing mechanical
prosthesis in the market. Building on this legacy and addressing
the largest market segment in heart valve therapy, the ATS 3f®
brand encompasses an innovative tissue heart valve portfolio to
address conventional open surgery requirements as well as the
growing demand for less invasive sutureless based procedures. The
ATS 3f® portfolio includes offerings at various stages including
early product development, pivotal clinical trials, and market
commercialization. Completing the portfolio in heart valve therapy
is the ATS Simulus® annuloplasty product line. Simulus products
assist the surgeon in repairing a patient's native heart valve as
an alternative to replacement. Continuing ATS Medical's focus on
serving the cardiac surgery community are the ATS CryoMaze®
products for surgical cryoablation of cardiac arrhythmias. ATS
CryoMaze® products are used by surgeons to treat patients suffering
from cardiac arrhythmias, the largest and fastest growing form of
structural heart disease in populations over 60 years of age. The
ATS Medical web site is http://www.atsmedical.com.
Cautionary Statements
This Press Release contains forward-looking statements that may
include statements regarding intent, belief or current expectations
of the Company and its management. Actual results could differ
materially from those projected in the forward-looking statements
as a result of a number of important factors, including the results
of clinical trials, the timing of regulatory approvals, the impact
of pending healthcare reforms, regulatory actions, competition,
pricing pressures, supplier actions and management of growth. For a
discussion of these and other risks and uncertainties that could
affect the Company's activities and results, please refer to the
Company's filings with the Securities and Exchange Commission,
including its Form 10-K for the year ended December 31, 2009 and
its most recent quarterly report on Form 10-Q.
Add to Digg Bookmark with del.icio.us Add to Newsvine
Contacts: Michael Dale President/CEO 763-553-7736 Michael Kramer
CFO 763-557-2222 Investors: Parice Halbert, CFA Westwicke Partners,
LLC 443-213-0500
Ats Medical (MM) (NASDAQ:ATSI)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Ats Medical (MM) (NASDAQ:ATSI)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024